Data / Form D filings / Gladius Pharmaceuticals Corp
Gladius Pharmaceuticals Corp: Form D filings
Gladius Pharmaceuticals Corp, a biotechnology company in Wilmington, DE, filed 2 Form D notices with the SEC between 2015 and 2018. The latest, on November 28, 2018, reports $3 million sold of a $3 million offering to 5 investors.
Find out what Gladius Pharmaceuticals Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2711 CENTERVILLE ROAD, SUITE 400, COUNTY NEWCASTLE, Wilmington, DE, 19808
- Phone
- (514) 213-4456
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1646819
The full lists. Form D filings in Delaware: 1,342 rows, $67.10, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 28, 2018 | New notice | $3,022,400 | $3,022,400 | $0 | 5 | Nov 14, 2018 | sec.gov |
| Jun 30, 2015 | New notice | $727,840 | $727,840 | $0 | 2 | Jun 22, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Atkin | Executive Officer | |
| Nathalie Chauret | Director | |
| Larry Sutton | Director | |
| Jens Eckstein | Director | |
| Daniel Hetu | Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Nov 26, 2018 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gladius Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.